New phase 1 data show potential for neurodegenerative disease treatment
Metabolic syndrome linked to faster brain ageing
Bowel cancer samples could boost understanding of other killer diseases
FDA clearance for non-muscle invasive bladder cancer treatment
New research brings personalised treatment for Parkinson’s disease closer
Greywolf Therapeutics and Genomics look to develop first‑in‑class autoimmune diseases treatments
Priority review for potential first approved treatment for warm autoimmune haemolytic anaemia
New first-in-class therapy for chronic graft-versus-host disease approved in Australia
Scientists discover new way to make drug-resistant cancer treatable
KAIST identifies viruses and variants simultaneously by controlling CRISPR speed​
Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression
ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma